Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.45 |
| ▸ | ACACB | O00763 | 6/20 | 0.45 |
| ▸ | EEF2K | O00418 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CKS1B | P61024 | 1/20 | 0.42 |
| ▸ | SKP1 | P63208 | 1/20 | 0.42 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.42 |
| ▸ | ACACA | Q13085 | 3/20 | 0.42 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5352632 | 0.88 | LMNA (0.48) | ACACBDRD2KMT2ACKS1BSKP1 | |
| SCHEMBL18766914 | 0.81 | EEF2K (0.46) | GPR119ACACBEEF2KDRD2CKS1B | |
| SCHEMBL18766917 | 0.81 | KMT2A (0.55) | GPR119ACACBEEF2KDRD2KMT2A | |
| SCHEMBL4554072 | 0.80 | MAPT (0.58) | ACACBDRD2CKS1BSKP1SKP2 | |
| SCHEMBL17718110 | 0.77 | CKS1B (0.48) | ACACBDRD2KMT2ACKS1BSKP1 | |
| SCHEMBL7137625 | 0.77 | ALDH1A1 (0.57) | ACACBDRD2KMT2APKM | |
| SCHEMBL5359104 | 0.74 | KDM4E (0.48) | ACACBDRD2CKS1BSKP1SKP2 | |
| SCHEMBL8217502 | 0.74 | ALDH1A1 (0.62) | ACACBDRD2KMT2ACKS1BSKP1 | |
| SCHEMBL18768436 | 0.74 | KDM4E (0.47) | GPR119ACACBEEF2KDRD2CKS1B | |
| SCHEMBL5729170 | 0.73 | CTSS (0.54) | CTSSCTSKKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1390034-A4 | N-SUBSTITUTED NONARYL-HETEROCYCLO AMIDYL NMDA/NR2B ANTAGONISTS | MERCK & CO INC (US) | 2005-07-13 | — | — | EP | disclosed |
| EP-1390034-A1 | N-SUBSTITUTED NONARYL-HETEROCYCLO AMIDYL NMDA/NR2B ANTAGONISTS | Merck & Co., Inc. (US) | 2004-02-25 | — | — | EP | disclosed |
| EP-1379520-A1 | N-SUBSTITUTED NONARYL-HETEROCYCLIC NMDA/NR2B ANTAGONISTS | Merck & Co., Inc. (US) | 2004-01-14 | — | — | EP | disclosed |
| WO-2002080928-A1 | N-SUBSTITUTED NONARYL-HETEROCYCLO AMIDYL NMDA/NR2B ANTAGONISTS | MERCK & CO., INC. (US) | 2002-10-17 | — | — | WO | disclosed |
| WO-2002068409-A1 | N-SUBSTITUTED NONARYL-HETEROCYCLIC NMDA/NR2B ANTAGONISTS | MERCK & CO., INC. (US) | 2002-09-06 | — | — | WO | disclosed |